Lohocla Research Corporation is dedicated to the research and development of innovative medications for chronic pain and addiction. Based in Aurora, United States, Lohocla focuses on addressing the debilitating effects of these conditions by exploring neural system maladaptations. The company aims to restore the full spectrum of life’s enjoyments to individuals suffering from severe chronic pain and addiction, which often isolate them from social connections.
Lohocla has made significant strides in understanding the neural mechanisms underlying chronic pain and addiction. By leveraging advanced bioscience research, the company has developed potential therapeutic solutions that target these complex conditions. Lohocla's commitment to innovation and its impact on improving quality of life for patients underscore its role as a leader in the field of chronic pain and addiction treatment.
